全文获取类型
收费全文 | 521篇 |
免费 | 5篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 2篇 |
妇产科学 | 10篇 |
基础医学 | 56篇 |
口腔科学 | 2篇 |
临床医学 | 39篇 |
内科学 | 129篇 |
皮肤病学 | 8篇 |
神经病学 | 31篇 |
特种医学 | 10篇 |
外科学 | 112篇 |
预防医学 | 25篇 |
眼科学 | 5篇 |
药学 | 39篇 |
肿瘤学 | 35篇 |
出版年
2023年 | 5篇 |
2022年 | 20篇 |
2021年 | 44篇 |
2020年 | 10篇 |
2019年 | 7篇 |
2018年 | 3篇 |
2017年 | 9篇 |
2016年 | 8篇 |
2015年 | 19篇 |
2014年 | 20篇 |
2013年 | 22篇 |
2012年 | 30篇 |
2011年 | 36篇 |
2010年 | 27篇 |
2009年 | 26篇 |
2008年 | 24篇 |
2007年 | 32篇 |
2006年 | 17篇 |
2005年 | 26篇 |
2004年 | 22篇 |
2003年 | 30篇 |
2002年 | 16篇 |
2001年 | 13篇 |
2000年 | 5篇 |
1999年 | 9篇 |
1998年 | 7篇 |
1997年 | 10篇 |
1996年 | 5篇 |
1995年 | 6篇 |
1994年 | 2篇 |
1993年 | 7篇 |
1992年 | 3篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1988年 | 1篇 |
1980年 | 1篇 |
1978年 | 1篇 |
排序方式: 共有526条查询结果,搜索用时 15 毫秒
1.
《Neuromuscular disorders : NMD》2022,32(1):25-32
Autoantibodies against 3?hydroxy-3-methylglutaryl-CoA reductase (HMGCR) and the signal recognition particle (SRP) are representative antibodies causing immune-mediated necrotizing myopathies (IMNM), called as anti-HMGCR and anti-SRP myopathies, respectively. Here, we analyzed the differences in routine blood test results between 56 anti-HMGCR and 77 anti-SRP myopathy patients. A higher alanine transaminase (ALT) level and a lower aspartate transaminase (AST)/ALT ratio were observed in anti-HMGCR myopathy patients [ALT, 265.7 ± 213.3 U/L (mean ± standard deviation); AST/ALT ratio, 0.88 ± 0.32] than in anti-SRP-myopathy patients (ALT, 179.3 ± 111.2 U/L, p < 0.05; AST/ALT ratio, 1.28 ± 0.40, p < 0.01). In the active phase, anti-HMGCR myopathy often showed ALT predominance, whereas anti-SRP myopathy often showed AST predominance. In addition, there were differences in erythrocyte sedimentation rate (ESR), total cholesterol (TChol) level, and high-density lipoprotein (HDL) level between anti-HMGCR and anti-SRP myopathies (ESR: HMGCR, 24.4 ± 20.8 mm/1 h; SRP, 35.7 ± 26.7 mm/1 h, p = 0.0334; TChol: HMGCR, 226.7 ± 36.6 mg/dL; SRP, 207.6 ± 40.8 mg/dL, p = 0.0163; HDL: HMGCR, 58.4 ± 13.9 mg/dL; SRP, 46.2 ± 17.3 mg/dL, p < 0.01). Additional studies on the differences in routine blood test results may further reveal the pathomechanisms of IMNM. 相似文献
2.
3.
《Journal of orthopaedic science》2022,27(3):707-712
BackgroundNo anti-adhesive materials are currently in clinical use for orthopaedic surgery. We developed a hyperdry amniotic membrane (HD-AM) for easy storage and transplantation as amniotic membrane. The purpose of this study was to examine the application of HD-AM to reduce peritendinous adhesions without impairing tendon healing.MethodsWe randomly divided 3 digits (2nd, 3rd, and 4th digits) from each rabbit into three groups: a tendon repair group; a tendon repair with HD-AM group (HD-AM group); and a control group (cast only). The effects of HD-AM on peritendinous adhesions and tendon healing were examined using microscopic, histological, and mechanical analyses in a rabbit flexor digitorum profundus tendon model.ResultsAdhesions on macroscopic evaluation of the tendon repair site were significantly smaller in the HD-AM group than in the tendon repair group. Little adhesion formation or foreign body reactions were seen by on histologic evaluation in the HD-AM group. Range of motion following tendon repair was significantly better in the HD-AM group than in the tendon repair group. Maximal tensile strength required to pull the tendon from the site of adhesion was significantly smaller in the HD-AM group than in the tendon repair group. As for tendon repair site, no significant difference was seen between the tendon repair and HD-AM groups.ConclusionsHD-AM prevented peritendinous adhesion macroscopically, pathologically, and mechanically without impairing the sutured tendon. HD-AM has already been clinically applied in neurosurgery, ophthalmology, and otolaryngology, and clinical application as an anti-adhesive materials may be achieved in the future. 相似文献
4.
Atsutoshi Ina Ken-Ichiro Hayashi Hiroshi Nozaki Yuto Kamei 《International journal of developmental neuroscience》2007,25(1):63-68
We identified and characterized a neurodifferentiation compound from the marine brown alga Sargassum fulvellum collected from the Japanese coastline. Several instrumental analyses revealed the compound to be pheophytin a. Pheophytin a did not itself promote neurite outgrowth of PC12 cells. However, when PC12 cells were treated with a low concentration of pheophytin a (3.9 microg/ml) in the presence of a low level of nerve growth factor (10 ng/ml), the compound produced neurite outgrowth similar to that produced by a high level of nerve growth factor (50 ng/ml). Pheophytin a also enhanced signal transduction in the mitogen-activated protein kinase signaling pathway, which is also induced by nerve growth factor. The effect of pheophytin a on neurite outgrowth of PC12 cells was completely blocked by U0126, a representative mitogen-activated protein kinase kinase inhibitor. These results suggest that pheophytin a enhances the neurodifferentiation of PC12 cells in the presence of a low level of nerve growth factor and that this effect is mediated by activation of a mitogen-activated protein kinase signaling pathway. 相似文献
5.
6.
Hiroyoshi Tsubochi Shunsuke Endo Kohzo Suhara Yasunori Sohara 《European journal of cardio-thoracic surgery》2007,31(6):1144-1146
Endobronchial aspergillosis or actinomycosis associated with broncholithiasis is extremely rare. Here, we describe two cases of endobronchial aspergillosis and actinomycosis associated with broncholithiasis. The patients underwent pulmonary resection due to massive hemoptysis. These cases reveal that a bronchiolith can potentially induce endobronchial fungal or bacterial infection, even in immunocompetent patients. 相似文献
7.
8.
Imai Sojiro Ookawara Susumu Ito Kiyonori Hattori Takashi Fueki Mariko Iguchi Miho Kiryu Satoshi Sanayama Hidenori Kakei Masafumi Tabei Kaoru Morishita Yoshiyuki 《Journal of artificial organs》2023,26(2):127-133
Journal of Artificial Organs - Few reports have examined the association between changes in cerebral oxygenation and clinical factors, including blood pressure (BP), upon standing after... 相似文献
9.
10.
S. Okubo K. Nakatani K. Nishiya 《Modern rheumatology / the Japan Rheumatism Association》2002,12(3):0226-0229
To investigate both the incidence and the dosage used to treat gastrointestinal (GI) symptoms associated with enteric-coated
sulfasalazine (Azulfidine EN, AZL) in patients with rheumatoid arthritis (RA), we studied the clinical history of 153 RA patients,
and any available data on GI symptoms that might have been associated with AZL. GI symptoms appeared in 64 (42.5%) of the
153 cases. There were 19 events of nausea, vomiting, or dyspepsia, 14 events each of epigastric discomfort and reduction or
loss of appetite, 10 events of epigastric, stomach, or abdominal pain, 9 events of heartburn, 8 events of mouth ulcer, 3 events
each of loss of taste and abdominal bloating or borborygmus, 2 events each of diarrhea or loose stools, hematemesis or melanemia,
and gastric or esophageal ulcer, and 1 event of stomatitis. These results indicate that GI symptoms associated with AZL are
usually mild and treatment can continue, with almost all cases responding to a reduction in dose or drug cessation. In some
cases, a histamine receptor-2 blocker or proton pump inhibitor is also required.
Received: October 11, 2001 / Accepted: March 29, 2002
Correspondence to: S. Okubo 相似文献